|
Delayed
Bombay S.E.
02:14:58 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,762.85 INR | -1.08% |
|
-1.69% | +50.06% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 222.05Cr | - | - | |||
| 4.67TCr | |||||
| 3.91TCr | |||||
| 1.17TCr | |||||
| 1.16TCr | |||||
| 918.87Cr |
Select your edition
All financial news and data tailored to specific country editions
